Total cholesterol and oxysterols: Early markers for cognitive decline in elderly?

Neurobiology of Aging

Volumn 30, Issue 4, 2009, Pages 534-545

  van den Kommer, T N ^a   Dik, M G ^a   Comijs, H C ^a   Fassbender, K ^b   Lutjohann D ^c   Jonker, C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Aging; ApoE 4; Cholesterol; Cognitive decline; Oxysterols

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN E4; CHOLESTEROL; CHOLESTEROL DERIVATIVE; OXYSTEROL;

ADULT; AGED; AGING; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; LEARNING; LONGITUDINAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; TASK PERFORMANCE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; BIOLOGICAL MARKERS; CAUSALITY; CHOLESTEROL; COGNITION; COGNITION DISORDERS; FEMALE; GENOTYPE; HUMANS; HYDROXYCHOLESTEROLS; HYPERCHOLESTEROLEMIA; LONGITUDINAL STUDIES; MALE; MEMORY; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 61649103345     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.08.005     Document Type: Article

References (52)

1. Abad-Rodriguez J., Ledesma M.D., Craessaerts K., Perga S., Medina M., Delacourte A., Dingwall C., De Strooper B., and Dottu C.G. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J. Cell Biol. 167 5 (2004) 953-960
2. Björkhem I., and Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24 5 (2004) 806-815
3. Björkhem I., Heverin M., Leoni V., Meaney S., and Diczfalusy U. Oxysterols and Alzheimer's disease. Acta Neurol. Scand. 114 (2006) 43-49
4. Bremmer M.A., Hoogendijk W.J.G., Deeg D.J.H., Schoevers R.A., Schalk B.W.M., and Beekman A.T.F. Depression in older age is a risk factor for first ischemic cardiac events. Am. J. Geriatr. Psychiatry 14 6 (2006) 523-530
5. Deeg D.J.H., and Westendorp-de Serière M. Autonomy and Well-Being in the Aging Population I: Report from the Longitudinal Aging Study Amsterdam 1992-1993 (1994), VU University Press, Amsterdam, The Netherlands
6. Dik M.G., Deeg D.J.H., Bouter L.M., Corder E.H., Kok A., and Jonker C. Stroke and apolipoprotein E ε4 are independent risk factors for cognitive decline: a population-based study. Stroke 31 10 (2000) 2431-2436
7. Dik M.G., Jonker C., Bouter L.M., Geerlings M.I., Van Kamp G.J., and Deeg D.J.H. APOE-ε4 is associated with memory decline in cognitively impaired elderly. Neurology 54 7 (2000) 1492-1497
8. Evans R.M., Emsley C.L., Gao S., Sahota A., Hall K.S., Farlow M.R., and Hendrie H. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology 54 1 (2000) 240-242
9. Evans R.M., Hui S., Perkins A., Lahiri D.K., Poirier J., and Farlow M.R. Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology 62 10 (2004) 1869-1871
10. Folstein M.F., Folstein S.E., and Mchugh P.R. Mini-mental state. A practical method for grading cognitive state of patients for the clinician. J. Psychiatr. Res. 12 3 (1975) 189-198
11. Hall K., Murrell J., Ogunniyi A., Deeg M., Baiyewu O., Gao S., Gureje O., Dickens J., Evans R., Smith-Gamble V., Unverzagt F.W., Shen J., and Hendrie H. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology 66 2 (2006) 223-227
12. Havekes L.M., De Knijff P., Beisiegel U., Havinga J., Smit M., and Klasen E. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J. Lipid Res. 28 4 (1987) 455-463
13. Heverin M., Bogdanovic N., Lütjohann D., Bayer T., Pikuleva I., Bretillon L., Diczfalusy U., Winblad B., and Björkhem I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 45 1 (2004) 186-193
14. Heverin M., Meaney S., Lütjohann D., Diczfalusy U., Wahren J., and Björkhem I. Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J. Lipid Res. 46 5 (2005) 1047-1052
15. Jarvik G.P., Wijsman E.M., Kukull W.A., Schellenberg G.D., Yu C., and Larson E.B. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 45 6 (1995) 1092-1096
16. Jolles J., Verhey F.R.J., Riedel W.J., and Houx P.J. Cognitive impairment in elderly people: predisposing factors and implications for experimental drug studies. Drugs Aging 7 6 (1995) 459-479
17. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., and Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 42 5 (1997) 776-782
18. Kivipelto M., Helkala E.L., Laakso M.P., Hanninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., and Nissien A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322 7300 (2001) 1447-1451
19. Kölsch H., Heun R., Kerksiek A., Von Bergmann K., Maier W., and Lütjohann D. Altered levels of plasma 24S-and 27-hydroxycholesterol in demented patients. Neurosci. Lett. 368 3 (2004) 303-308
20. Kriegsman D.M.W., Penninx B.W.J.H., Van Eijk J., Boeke A.J.P., and Deeg D.J.H. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinations of inaccuracy. J. Clin. Epidemiol. 49 (1996) 1407-1417
21. Kuusisto J., Koivisto K., Mykkanen L., Helkala E.L., Vanhanen M., Hanninen T., Kervinen K., Kesaniemi Y.A., Riekkinen P.J., and Laakso M. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 315 7115 (1997) 1045-1049
22. Laurin D., Verreault R., Lindsay J., Dewailly E., and Holub B.J. Omega-3 fatty acids and risk of cognitive impairment and dementia. J. Alzheimer's Dis. 5 4 (2003) 315-322
23. Lehtimäki T., Ojala P., Rontu R., Goebeler S., Karhunen P.J., Jylhä M., Mattila K., Metso S., Jokela H., Nikkilä M., Wuolijoki E., Hervonen A., and Hurme M. Interleukin-6 modulates plasma cholesterol and C-reactive protein concentrations in nonagenarians. J. Am. Geriatr. Soc. 53 9 (2005) 1552-1558
24. Leoni V., Masterman T., Patel P., Meaney S., Diczfalusy U., and Björkhem I. Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers. J. Lipid Res. 44 4 (2003) 793-799
25. Lütjohann D., Breuer O., Ahlborg G., Nennesmio I., Siden A., Diczfalusy U., and Björkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. U.S.A. 93 18 (1996) 9799-9804
26. Lütjohann D., Papassotiropoulos A., Björkhem I., Locatelli S., Bagli M., Oehring R.D., Schlegel U., Jessen F., Rao M.L., Von Bergmann K., and Heun R. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 41 2 (2000) 195-198
27. Lütjohann D., Stroick M., Bertsch T., Kuhl S., Lindenthal B., Thelen K., Andersson U., Björkhem I., Von Bergmann K., and Fassbender K. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids 69 (2004) 431-438
28. Michikawa M. Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function. Acta Neurol. Scand. 114 (2006) 21-26
29. Mielke M.M., Zandi P.P., Sjögren M., Gustafson D., Ostling S., Steen B., and Skoog I. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 64 10 (2005) 1689-1695
30. Moller J.T., Cluitmans P., Rasmussen L.S., Houx P., Rasmussen H., Canet J., Rabbitt P., Jolles J., Larsen K., Hanning C.D., Langeron O., Johnson T., Lauven P.M., Kristensen P.A., Biedler A., Van Beem H., Fraidakis O., Silverstein J.H., Beneken J.E.W., and Gravenstein J.S. Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study. Lancet 351 9106 (1998) 857-861
31. Notkola I.L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., Tuomilehto A., and Nissinen A. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17 1 (1998) 14-20
32. Panza F., D'Introno A., Colacicco A.M., Capurso C., Pichichero G., Capurso S.A., Capurso A., and Solfrizzi V. Lipid metabolism in cognitive decline and dementia. Brain Res. Rev. 51 2 (2006) 275-292
33. Papassotiropoulos A., Lütjohann D., Bagli M., Locatelli S., Jessen F., Rao M.L., Maier W., Björkhem I., Von Bergmann K., and Heun R. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. Neuroreport 11 9 (2000) 1959-1962
34. Pappolla M.A., Bryant-Thomas T.K., Herbert D., Pacheco J., Garcia M.F., Manjon M., Girones X., Henry T.L., Matsubara E., Zambon D., Wolozin B., Sano M., Cruz-Sanchez F.F., Thal L.J., Petanceska S.S., and Refolo L.M. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61 2 (2003) 199-205
35. Piccinin A.M., and Rabbitt P.M. Contribution of cognitive abilities to performance and improvement on a substitution coding task. Psychol. Aging 14 4 (1999) 539-551
36. Pitas R.E., Boyles J.K., Lee S.H., Foss D., and Mahley R.W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917 1 (1987) 148-161
37. Poirier J. Apolipoprotein E in the brain and its role in Alzheimer's disease. J. Psychiatry Neurosci. 21 2 (1996) 128-134
38. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977) 385-401
39. Reinhard O., and Rood-Bakker D. Alcoholgebruik in beeld. Standaardmeetlat (1998), Nederlands Economisch Instituut, Rotterdam (in Dutch)
40. Rey A. L'examen clinique en psychologie (1964), Presses Universitaire de France, Paris, France
41. Romas S.N., Tang M.X., Berglund L., and Mayeux R. APOE genotype, plasma lipids lipoproteins, and AD in community elderly. Neurology 53 3 (1999) 517-521
42. Salthouse T.A. The processing-speed theory of adult age differences in cognition. Psychol. Rev. 103 3 (1996) 403-428
43. Schalk B.W.M., Visser M., Deeg D.J.H., and Bouter L.M. Lower levels of serum albumin and total cholesterol and future decline in functional performance in older persons: the Longitudinal Aging Study Amsterdam. Age Ageing 33 3 (2004) 266-272
44. Solfrizzi V., Panza F., D'Introno A., Colacicco A., Capurso C., Basile A.M., and Capurso A. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 72 6 (2002) 732-736
45. Solfrizzi V., D'Introno A., Colacicco A.M., Capurso C., Todarello O., Pellicani V., Capurso S.A., Pietrarossa G., Santamato V., Capurso A., and Panza F. Circulating biomarkers of cognitive decline and dementia. Clin. Chim. Acta 364 1/2 (2006) 91-112
46. Solomon A., Kåreholt I., Ngandu T., Winblad B., Nissinen A., Tuomihelto J., Soininen H., and Kivipelto M. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology 68 10 (2007) 751-756
47. Tan Z.S., Seshadri S., Beiser A., Wilson P.W.F., Kiel D.P., Tocco M., D'Agostino R.B., and Wolf P.A. Plasma total cholesterol level as a risk factor for Alzheimer disease-The Framingham study. Arch. Intern. Med. 163 9 (2003) 1053-1057
48. Teunissen C.E., De Vente J., Von Bergmann K., Bosma H., Van Boxtel M.P., De Bruijn C., Joplles J., Steinbusch H.W., and Lütjohann D. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. Neurobiol. Aging 24 1 (2003) 147-155
49. Twisk J.W., and De Vente W. Roaming through methodology. XXII. Application of techniques for longitudinal data analysis. Ned. Tijdschr. Geneeskd. 144 35 (2000) 1680-1683 (in Dutch)
50. van den Heuvel N., Smits C.H.M., Deeg D.J.H., and Beekman A.T.F. Personality: a moderator of the relation between cognitive functioning and depression in adults aged 55-85?. J. Affect. Disord. 41 (1996) 229-240
51. van Gelder B.M., Tijhuis M., Kalmijn S., and Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am. J. Clin. Nutr. 85 4 (2007) 1142-1147
52. Wirths O., Thelen K., Breyhan H., Lúzon-Toro B., Hoffmann K.H., Falkai P., Lütjohann D., and Bayer T.A. Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease. Exp Gerontol 41 2 (2006) 220-224